What is the evidence‑based treatment for tinea capitis caused by Trichophyton rubrum or Trichophyton violaceum?

Treatment of Tinea Capitis Caused by Trichophyton rubrum/violaceum

For tinea capitis caused by Trichophyton rubrum or T. violaceum, use oral terbinafine as first-line therapy, dosed by weight for 2-4 weeks, as it demonstrates superior efficacy against Trichophyton species compared to griseofulvin. 1

First-Line Treatment: Terbinafine

The British Association of Dermatologists guidelines explicitly state that terbinafine is more efficacious against Trichophyton species, including T. violaceum and T. soudanense 1. This is critical because terbinafine is fungicidal and shows much higher efficacy against Trichophyton species than Microsporum 1.

Weight-Based Dosing:

• < 20 kg: 62.5 mg daily for 2-4 weeks
• 20-40 kg: 125 mg daily for 2-4 weeks
• > 40 kg: 250 mg daily for 2-4 weeks 1

Key Advantages:

• Shorter treatment duration (2-4 weeks vs 6-8 weeks for griseofulvin), which improves compliance 1
• Fungicidal mechanism of action 1
• Well-tolerated with GI disturbances and rashes in <8% of patients, with only 0.8% requiring discontinuation 1

Alternative First-Line: Griseofulvin

While griseofulvin remains the only licensed treatment for tinea capitis in children in the UK 1, it is less effective against Trichophyton species in clinical practice and requires higher doses for longer periods (12-18 weeks) for Trichophyton infections 1.

When to Consider Griseofulvin:

• Licensing restrictions prevent terbinafine use
• Patient cannot tolerate terbinafine
• Cost considerations in resource-limited settings

Dosing if Used:

• < 50 kg: 15-20 mg/kg/day (may need up to 25 mg/kg/day) for 6-8 weeks (potentially 12-18 weeks for Trichophyton)
• > 50 kg: 1 g daily for 6-8 weeks 1

Important: Take with fatty food to increase absorption 1

Second-Line Therapy

If treatment fails with terbinafine, switch to itraconazole 1:

• 50-100 mg daily for 4 weeks, or
• 5 mg/kg/day for 2-4 weeks

Itraconazole has activity against both Trichophyton and Microsporum species and is safe and effective 1.

Alternative Agents for Refractory Cases

Fluconazole has demonstrated eradication of T. violaceum 1:

• Evidence shows efficacy comparable to other agents 2
• Once-weekly dosing regimens available and well-tolerated 1
• 6 mg/kg/day for 2-3 weeks based on research evidence 2

Voriconazole is more potent than griseofulvin or fluconazole but limited by cost and licensing 1

Critical Management Points

Before Starting Treatment:

• Obtain scalp scrapings, hair plucks, or brush samples for microscopy and culture 1
• Do not wait for culture results if cardinal signs present (scale, lymphadenopathy, alopecia, or kerion) 1
• Topical therapy alone is inadequate—oral therapy is required for mycological cure 1

Treatment Failure Algorithm:

1. First, assess: compliance, drug absorption, reinfection 1
2. If clinical improvement but positive mycology: Continue current therapy 2-4 more weeks 1
3. If no clinical improvement: Switch to second-line therapy (itraconazole) 1

Monitoring:

• Endpoint is mycological cure, not clinical cure 1
• Repeat mycology sampling until clearance achieved 1
• Final evaluation typically at week 12 2

Additional Measures

• Children on appropriate therapy can attend school/nursery 1
• Screen family members and close contacts, especially with anthropophilic species 1
• Treat asymptomatic carriers with high spore loads 1
• Check for concurrent dermatophyte infections at other body sites (occurs in 33.5% of cases) 3

Common Pitfalls to Avoid

1. Don't use griseofulvin at standard doses for Trichophyton infections—it requires higher doses (up to 25 mg/kg/day) and longer duration (12-18 weeks) 1
2. Don't stop at clinical improvement—continue until mycological clearance 1
3. Don't assume treatment failure is drug resistance—first check compliance and absorption 1
4. Don't forget to examine other body sites—tinea pedis and onychomycosis are common sources 4, 3